Barely Significant
← all excerpts

Clinical characteristics and therapeutic determinants of <i>RUNX1::RUNX1T1</i> differ from those of <i>CBFB::MYH11</i> acute myeloid leukemia.

Haematologica · 2025 · PMC12485314 · PMID 40304077

Europe PMCDOI
1
hedged sentence
0.0820
closest p · 1.6× alpha
0.0820
boldest claim

The sentences

showed a trendP =0.082so close (0.05 < p ≤ 0.1)
Among CBFB::MYH11 patients, trisomy 8 showed a trend toward better RFS at 100% versus 69.0±5.3% ( P =0.082), while OS remained comparable between groups at 100% versus 85.7±3.4% ( P =0.21) ( Online Supplementary Figure S4A, B ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.